Scott Walshco
President and CEO
Replay available
Fate Therapeutics, Inc. (FATE) Q2 2023 Earnings Call
Fate Therapeutics, Inc. (NASDAQ: FATE) Q2 2023 earnings conference call, held 2023-08-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Ed Duloc
Chief Financial Officer
Bob Vollumer
Chief Research and Development Officer
Ashok Mubarak
Analyst (Citi)
Michael Yee
Analyst (Jefferies)
Jerry Gongong
Representative for Mara Goldstein (Mizuho)
Bill Morgan
Analyst (Canaccord Genuity)
Jack Allen
Analyst (Baird)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fate Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:04.852 Welcome to the FATE Therapeutics second quarter 2023 financial results conference call. 00:00:04.852 -- 00:00:07.594 At this time, all participants are on listen-only mode. 00:00:07.594 -- 00:00:13.517 This call is being webcast live on the investor section of FATE's website at fatetherapeutics.com. 00:00:13.517 -- 00:00:16.199 As a reminder, today's call is being recorded. 00:00:16.199 -- 00:00:21.261 I would now like to introduce Scott Walshco, President and CEO of FATE Therapeutics. 00:00:21.882 -- 00:00:26.425 Thank you. Good afternoon, and thanks, everyone, for joining us for the FATE Therapeutics 00:00:26.425 -- 00:00:29.826 second quarter 2023 financial results call. 00:00:30.618 -- 00:00:36.279 Shortly after 4 p.m. Eastern time today, we issued a press release with these results, 00:00:36.279 -- 00:00:41.280 which can be found on the Investors section of our website under Press Releases. 00:00:41.280 -- 00:00:46.611 In addition, our Form 10-Q for the quarter ended June 30, 2023, 00:00:46.902 -- 00:00:51.322 was filed shortly thereafter and can be found on the Investors section of our website 00:00:51.322 -- 00:00:53.723 under Financial Information. 00:00:53.723 -- 00:00:58.044 Before we begin, I'd like to remind everyone that except for statements of historical 00:00:58.044 -- 00:01:03.065 facts, The statements made by management and responses to questions on this conference 00:01:03.065 -- 00:01:08.388 call are forward looking statements under the safe harbor provisions of the Private 00:01:08.388 -- 00:01:13.611 Securities Litigation Reform Act of 1995. These statements involve 00:01:13.611 -- 00:01:18.974 risks and uncertainties that can cause actual results to differ materially 00:01:18.974 -- 00:01:21.976 from those in...